Further large-scale longitudinal studies wherein the subjects are followed over a long period of time (evaluation from insulin sensitive to obesity to insulin resistance and T2DM) would confirm a potential and dynamic change in microbiome status, genetic diversity, and general metabolic response with diverse statuses of glucose metabolism, and could determine causality. The gene discussed is INS; the disease is Insulin resistance.